Bionoid Pharma Inc. (BINP)
OTCMKTS
· Delayed Price · Currency is USD
0.1100
+0.0023 (2.14%)
May 27, 2025, 9:30 AM EDT
Bionoid Pharma Revenue
In the year 2013, Bionoid Pharma had annual revenue of $92.26K.
Revenue
92.26K
Revenue Growth
n/a
P/S Ratio
64.38
Revenue / Employee
18.45K
Employees
5
Market Cap
5.94M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Endo Inc. | 1.73B |
| Veradigm | 588.02M |
| Tian'an Technology Group | 1.78M |
| Elite Pharmaceuticals | 70.00M |
| Glass House Brands | 215.62M |
| Northwest Biotherapeutics | 1.47M |
| Silence Therapeutics | 27.70M |
| BioStem Technologies | 332.45M |
Bionoid Pharma News
- 11 days ago - Bionoid Pharma, Inc. Rebrands as AI Maverick Intel, Inc. to Reflect Strategic Shift Toward AI-Driven Innovation - Accesswire
- 6 weeks ago - Bionoid Pharma Inc. Announces Completion of 2024 Financial Audit - Accesswire
- 6 weeks ago - Bionoid Pharma Inc. Engages Aloba, Awomolo & Partners as External Auditor for 2024 Financial Statements - Accesswire
- 2 months ago - Bionoid Pharma Announces Filing of OTCQB Application to Enhance Market Visibility and Liquidity - Accesswire
- 2 months ago - Bionoid Pharma, Inc. Announces Completion of 2022 and 2023 Financial Audits by PCAOB-Registered Firm - Accesswire
- 4 months ago - Bionoid Pharma, Inc. Provides Corporate Update and Outlines Growth Strategy for 2025 - Accesswire
- 4 months ago - Bionoid Pharma, Inc. Reports Over $100,000 in Revenue Following Binding LOI With Your Supplement Supply Store Ltd. - Accesswire
- 5 months ago - Bionoid Pharma, Inc. Moves to Expand E-Commerce Presence With Binding Agreement to Acquire Platform From Vitawin Supplements Ltd. - Accesswire